济南男人早射秒射怎么办(济南怎么治疗前列腺炎早泄) (今日更新中)

SUVA, March 14 (Xinhua) -- Some 300 diabetes patients undergo amputations every year in Fiji and the trend is worrying the authorities.This is according to research carried out by the country's Physiotherapy Associations which shows that majority of these amputations occur in the 40 to 60 age group, physiotherapist Lusia Tikolevu told radio FijiVillage website on Monday.Tikolevu said that they are trying to formulate a protocol for physicist to better understand diabetes in Fiji.A visit to the Colonial War Memorial Hospital in Fiji's capital city of Suva by Xinhua reporter reveals the increasing number of bed ridden patients affected by diabetes in wards.Tikolevu said that diabetes is a prevalent disease and needs the involvement of the whole community for a successful preventative measures.Shocking figures show four out of every 10 people in Fiji have diabetes, putting it amongst the highest in the world.The Fred Hollows Foundation in New Zealand that completed the first survey of its kind in Fiji also showed the diabetic rate in the island nation is four times more than in New Zealand.The survey across 34 communities in Fiji found 40 percent of the people have diabetes."When we found out that 40 percent of the population had diabetes the scope and the depth of the problem just hit us. The impact in terms of costs family aspects, economic issues its just going to be staggering," says Doctor Tom Schaefer from the New Zealand foundation.The survey results also showed a third of those with diabetes did not know they had the disease and women were almost twice as likely as men to have it.The magnitude of the problem is worrying for a health system which has committed staff but little resources."The cost of medication alone is going to outstrip the ability of any health system to do it," says Schaefer.The existence of the sugar cane industry in the island nation may be a contributing factor to the high level of diabetics.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.

CAIRO, Jan. 23 (Xinhua) -- As part of bilateral efforts to enhance cultural cooperation between the two great civilizations, China, as the Guest of Honor, will participate in the 43rd Cairo International Book Fair in Egypt."An outstanding Chinese delegation will attend the fair to inform the Egyptian people all about Chinese culture," said Chen Dongyun, cultural counsellor of the Chinese Embassy in Egypt.Some 248 publishers, 13 renowned scholars, writers and artists will display about 10,000 books about the achievements made by China in various fields such as politics, economy, science and technology, and culture.The fair, the most important of its kind in the Arab region, will be held on Jan. 29 through Feb. 8 in the Cairo International Conference Center. The annual fair began in 1969.The Chinese hall in the center covers an area of 1,400 square meters, with special areas allocated for a variety of exhibitions about the history of the evolution of Chinese characters, photos reflecting Sino-Egypt friendship and landscape of modern China and intangible cultural heritage.The fair also includes a seminar featuring literature and translation among Chinese and Egyptian writers and artists and a week-long film show in which six Chinese films with Arabic subtitles will be introduced to the audience.Chinese participation reflected the common consensus of the leaders of the two countries to deepen mutual understanding and friendship and will serve to promote the sound and sustainable development of bilateral relations, Chen said.Zhang Jichen, vice president of China National Publications Import and Export (Group) Corporation, which is in charge of the organization of the Chinese activities at the fair, said a cooperation agreement between the General Administration of Press and Publication of China and Egypt's Ministry of Culture.China will also present some 1,000 high-quality books to the National Library and Archives of Egypt and the Alexandria Library.The fair is expected to attract 632 publishers from 29 countries, including 17 in the Middle East. More than two million visitors participate in the fair each year.

ROME, May 26 (Xinhua) -- African swine fever, a viral disease deadly to pigs but harmless to human beings, is spreading beyond Russia and the Caucasus region into Europe, the United Nations' food agency said Thursday."African swine fever is fast becoming a global issue," said Juan Lubroth, chief veterinary officer for the Food and Agriculture Organization."It now poses an immediate threat to Europe and beyond. Countries need to be on the alert and to strengthen their preparedness and contingency plans," he said.The disease, for which there is currently no vaccine, was introduced into Georgia from southern Africa late in 2006. It entered through the Black Sea port of Poti, where garbage from a ship was taken to a dump where pigs came to feed, the FAO said.Strategies to tackle African swine fever include quarantine, on-farm security and other measures aimed at minimizing the risk of introduction and establishing of the disease.

BEIJING, March 21 (Xinhuanet) -- A new device is being developed by American engineers to ease pain of blood sugar testing in diabetics, according to foreign media report last week.The upcoming device is the research target of a team of engineers at Arizona State University. It is specifically designed for patients with type1diabetes and type2 diabetes, according to a report in the "Journal of Diabetes Science and Technology,"  The traditional method of testing blood sugar levels involves painful pricks on the fingers to draw blood for testing. The inconvenient and painful process may somehow leave diabetics lax in their testing. The blood sugar levels, when poorly controlled, are very likely to trigger complications including heart disease, kidney disease and retinopathy.Unlike the old testing method, the new device could help people keep track of their blood sugar levels without the need to break the skin. It draws tears to measures the blood sugar levels in the fluid and gives just an accurate reading of blood sugar levels. "This new technology might encourage patients to check their blood sugars more often, which could lead to better control of their diabetes by a simple touch to the eye." said Jeffrey T. LaBelle, developer of the device.The new testing device has drawn great interest from investors due to its promising prospects. However, it still awaits a significant amount of testing before it can hit the market.

来源：资阳报